News from ANSIRH
Search publications
Search publications
Research on Abortion
Research on Abortion
Research at ANSIRH
Research at ANSIRH
Research on Contraception
Research on Contraception
Research on Culture
Research on Culture
International Research
International Research
Research on Policy
Research on Policy
ANSIRH publications
ANSIRH publications
ANSIRH publications
ANSIRH publications
ANSIRH publications & resources
ANSIRH publications & resources
ANSIRH publications
ANSIRH publications
ANSIRH training materials
ANSIRH training materials
ANSIRH training materials
ANSIRH training materials
ANSIRH in the Media
ANSIRH in the Media
ANSIRH publications & resources
ANSIRH publications & resources
ANSIRH resources
ANSIRH resources
ANSIRH resources
ANSIRH resources
ANSIRH resources
ANSIRH resources

Article

Sixteen years after FDA approval, mifepristone's potential is still limited by restrictions

​Mifepristone was approved in by the US Food and Drug Administration on September 28, 2000. Sixteen years later, the hoped-for improvements in access to abortion due to this drug have not been fully realized. In an opinion piece in US News & World Report, ANSIRH Director Dr. Dan Grossman explores the state laws and federal regulations that are limiting access to medication abortion. From laws banning telemedicine to provide abortion to FDA regulations preventing pharmacy dispensing of mifepristone, a range of policies make it difficult for women to use this safe and effective abortion option. After 16 years of experience with mifepristone in the US, Dr. Grossman argues that it is time to remove the remaining restrictions on medication abortion.

Read the op-ed here: http://www.usnews.com/opinion/articles/2016-09-30/its-long-past-time-to-remove-abortion-pill-restrictions

Banner photo: © Aura Orozco-Fuentes

Sign up for the ANSIRH Listserv

Want to stay up to date on the latest research and news from ANSIRH? Join our listserv.

Contact us

Connect with us on social media

ANSIRH is a program within the UCSF Bixby Center for Global Reproductive Health and is a part of UCSF's Department of Obstetrics, Gynecology & Reproductive Sciences.

©2015 The Regents of the University of California